Michael Ricciardi, Ph.D.
Energizer · DISC type IMichael Ricciardi is the Executive Director of Translational Research at The George Washington University, where he leads projects developing monoclonal antibodies for infectious diseases like COVID-19, HIV, and Zika. He holds a Ph. D. in Biochemistry and Molecular Biology from the University of Miami Miller School of Medicine and has extensive experience in commercializing biomedical products.
He is a driven entrepreneur, having co-founded two biotechnology companies, MABloc Therapeutics and MAT Biologics. These companies focus on antibody discovery and development, and the acquisition of human samples for research, respectively, showcasing his passion for translating scientific discoveries into practical solutions for global health challenges.
Unique fact: Michael is a co-inventor on a patent for a broadly-neutralizing antibody designed to combat COVID-19 and other coronaviruses.
Read the full overview →How Michael shows up
They are people oriented, friendly and like creating new connections. They excel at seeing the bigger picture, and the long-term impact of their decisions. They are not always early adopters but can be pursuaded by leveraging strong relationships.
Topics Michael cares about
Work history
Media appearances
DISC profile (public)
Influence (I)
Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.
Other The George Washington University Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.